E-LIB Suche - Ergebnisse für: Bellone, M.

1

EE79 Cost-Utility Analyses of Glofitamab for the Treatment ..:

Bellone, M. ; Ghislieri, D. ; Pradelli, L...
Value in Health. 26 (2023) 12 - p. S65 , 2023

Link: https://doi.org/10.1016/..

2

POSC113 Fixed-Dose Combination of Pertuzumab and Trastuzuma..:

Bellone, M ; Pradelli, L ; Sanfilippo, A...
Value in Health. 25 (2022) 1 - p. S109 , 2022

Link: https://doi.org/10.1016/..

3

EE115 Cost-Effectiveness and Cost-Utility Analyses of Polat..:

Bellone, M ; Pradelli, L ; Ghislieri, D
Value in Health. 25 (2022) 12 - p. S75-S76 , 2022

Link: https://doi.org/10.1016/..

4

EE223 Economic Consequences of Administering Obinutuzumab a..:

Bellone, M ; Pradelli, L ; Tavarozzi, R...
Value in Health. 25 (2022) 12 - p. S97 , 2022

Link: https://doi.org/10.1016/..

5

POSA108 A Budget Impact Analysis of Atezolizumab Monotherap..:

Pradelli, L ; Bellone, M ; Heaton, E...
Value in Health. 25 (2022) 1 - p. S54 , 2022

Link: https://doi.org/10.1016/..

6

EE107 Ponesimod Indicated for Patients With Active Relapsin..:

Bellone, M ; Pradelli, L ; Rizzato, M.
Value in Health. 25 (2022) 12 - p. S74 , 2022

Link: https://doi.org/10.1016/..

7

POSB109 Cost-Effectiveness and Cost-Utility Analyses of Pol..:

Bellone, M ; Pradelli, L ; Caputo, A...
Value in Health. 25 (2022) 1 - p. S82 , 2022

Link: https://doi.org/10.1016/..

8

POSB108 Cost-Effectiveness and Cost-Utility Analyses of Ate..:

Pradelli, L ; Bellone, M ; Sanchez Alvarez, J..
Value in Health. 25 (2022) 1 - p. S82 , 2022

Link: https://doi.org/10.1016/..

9

The plant diterpene epoxysiderol targets Hsp70 in cancer ce..:

Fiengo, L. ; Lauro, G. ; Bellone, M.L....
International Journal of Biological Macromolecules. 189 (2021) - p. 262-270 , 2021

Link: https://doi.org/10.1016/..

10

PCN66 Cost-Effectiveness Model Adapted to Italian Clinical ..:

Bellone, M. ; Pradelli, L. ; Gancitano, G..
Value in Health. 23 (2020) - p. S433 , 2020

Link: https://doi.org/10.1016/..

11

PCN85 An Updated Cost-Utility Analysis in Italian Patients ..:

Bellone, M. ; Pradelli, L. ; Gancitano, G..
Value in Health. 23 (2020) - p. S436-S437 , 2020

Link: https://doi.org/10.1016/..

12

PCN147 ENTRECTINIB IN NTRK TUMOR AGNOSTIC INDICATION COMPAR..:

Bellone, M. ; Zaniolo, O. ; Martinelli, E....
Value in Health. 22 (2019) - p. S464 , 2019

Link: https://doi.org/10.1016/..

13

PCN148 COST-UTILITY OF ENTRECTINIB VERSUS CRIZOTINIB IN ROS..:

Bellone, M. ; Zaniolo, O. ; Martinelli, E....
Value in Health. 22 (2019) - p. S464 , 2019

Link: https://doi.org/10.1016/..

14

PCN156 COST-EFFECTIVENESS ANALYSIS OF OBINUTUZUMAB FOR PREV..:

Bellone, M. ; Pradelli, L. ; Friggi, E..
Value in Health. 22 (2019) - p. S465-S466 , 2019

Link: https://doi.org/10.1016/..

15

Development and validation of a novel EPS-metabolomic signa..:

Cucchiara, V. ; Andolfo, A. ; Drago, D....
European Urology Supplements. 18 (2019) 9 - p. e3342 , 2019

Link: https://doi.org/10.1016/..